Diwakar Davar

Diwakar Davar

Company: UPMC

Job title: Assistant Professor, Melanoma and Phase I Therapeutics


Diwakar Davar, MBBS, M.Sc. is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers.; 

Dr. Davar is board-certified in internal medicine and medical oncology. He received his medical degree from National University of Singapore and completed both his residency and fellowship at UPMC. 

Dr. Davar is a member of many professional organizations, including the American Association for Cancer Research, American Society of Clinical Oncology, Allegheny County Medical Society, American College of Physicians, and Singapore Medical Association. 


Live Q&A 12:20 pm

Read more

day: Online Conference

Neoadjuvant Evaluation of TLR9 Agonist CMP-001 in Melanoma 11:20 am

• Neoadjuvant TLR9 agonist CMP-001 in combination with PD-1 inhibitor Nivolumab produces high pathologic response rates in PD-1 naive high-risk respectable melanoma • Neoadjuvant treatment response is associated with other biomarkers of response including circulating Ki67 high CD8+ T cells and CD8 TIL • Response to neoadjuvant therapy is associated with durable RFSRead more

day: Online Conference

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.